Search the GHTC website

Global health R&D delivers for New Jersey

US government investment in global health R&D has delivered

Amount
$114.8 million
to New Jersey research institutions
Jobs
1,400+ new jobs
for New Jersey
New Jersey's top USG-funded global health R&D institutions

New Jersey's top USG-funded global health R&D institutions

Rutgers University (including US Public Health Research Institute, Rutgers Biomedical and Health Sciences, Robert Wood Johnson Medical School, and the University of Medicine and Dentistry of New Jersey)
$105.2 million
Princeton University
$9.3 million
Drew University
$384 thousand
New Jersey industry in global health R&D

New Jersey industry in global health R&D

Alere
Location(s): Freehold
Allied Innovative Systems
Location(s): Chatham
AMT
Location(s): Cherry Hill
ARTANN Laboratories
Location(s): West Trenton
BASF Corporation
Location(s): Florham Park, Iselina
Bayer
Location(s): Parsippany, Whippany
Bristol-Myers Squibb
Location(s): Bloomsburg, Hopewell, Nassau Park, New Brunswick, Lawrenceville, Plainsboro, Princeton Pike
Cayoll
Location(s): Orange
Celgene
Location(s): Basking Ridge, Berkley Heights, Summit, Warren
Charles River Laboratories
Location(s): Fairfield
Daiichi Sankyo
Location(s): Basking Ridge
Eisai
Location(s): Woodcliff Lake
Ipca Pharmaceuticals
Location(s): South Plainfield
Jacobus Pharmaceutical
Location(s): Plainsboro, Princeton
Janssen
Location(s): Raritan, Somerset, Titusville
Johnson & Johnson
Location(s): New Brunswick
Location(s): Newark
Merck & Co
Location(s): Kenilworth, Rahway
Novartis
Location(s): East Hanover, Princeton, Morris Plains
PortaScience
Location(s): Moorestown
PTC Therapeutics
Location(s): South Plainfield
Regeneron
Location(s): Basking Ridge
Roche
Location(s): Branchburg
Sandoz
Location(s): East Hanover, Princeton
Sanofi
Location(s): Bridgewater
Snowdon
Location(s): Monmouth Junction
Scynexis
Location(s): Jersey City
Temptime
Location(s): Morris Plains
VaxInnate Corporation
Location(s): Cranbury
Zydus Pharmaceuticals
Location(s): Pennington

New Jersey's top areas of global health R&D by USG funding

22.9%
HIV/AIDS
6.6%
Malaria
59.2%
Tuberculosis
2.3%
Diarrheal diseases
5.5%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Leprosy
3.5%
Other
Bacterial pneumonia & meningitis
Global health R&D at work in New Jersey

Rutgers New Jersey Medical School has helped develop a new rapid test for tuberculosis (TB). The test, Xpert® MTB/RIF Ultra, is a second-generation version of a test that revolutionized TB diagnosis. Like its predecessor, Ultra is fast, accurate, easy to use, and needs no extra equipment—making it particularly suitable for low-resource settings. But Ultra is better able to detect TB in children, people with HIV, and certain drug-resistant cases. Results from Ultra allow patients to start on treatment quickly, increasing treatment success rates and reducing the spread of the world’s top infectious killer.

Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: © 2013 Michael Tran/Interactive Research and Development, Courtesy of Photoshare